Table 1.
Characteristics of Women Aged 30–64 Years With Cervical Cancer in Texas, 2014–2018a by Stage of Diagnosisb
| Characteristics | All CC (n=5,060; 100%) patients, No. (%) | Early-stage CC (n=2,208; 43.6%) patients, No. (%) | Late-stage CC (n=2,241; 44.3%) patient, No. (%) | Unstaged CC (n=611; 12.1%) patient, No. (%) | p-valuec |
|---|---|---|---|---|---|
| Age, mean (SD) | 45.7 (9.6) | 43.6 (9.3) | 47.8 (9.3) | 45.6 (9.9) | <0.001 |
| Age, median (IQR) | 45 (38–54) | 42 (36–51) | 48 (40–55) | 45 (37–54) | <0.001 |
| Age, years | <0.001 | ||||
| 30–44 | 2,482 (41.1) | 1,303 (52.6) | 881 (31.7) | 298 (37.9) | |
| 45–54 | 1,443 (23.9) | 537 (21.7) | 740 (26.6) | 166 (21.1) | |
| 55–64 | 1,135 (18.8) | 368 (14.9) | 620 (22.3) | 147 (18.7) | |
| Race/ethnicity | <0.001 | ||||
| Hispanic | 1,840 (36.4) | 788 (35.7) | 851 (38.0) | 201 (32.9) | |
| NHB | 591 (11.7) | 204 (9.2) | 315 (14.1) | 72 (11.8) | |
| NHW | 2,397 (47.4) | 1,099 (49.8) | 999 (44.6) | 299 (48.9) | |
| Otherd | 232 (4.6) | 117 (5.3) | 76 (3.4) | 39 (6.4) | |
| Payer at diagnosise | <0.001 | ||||
| Private | 2,128 (42.1) | 1,176 (53.3) | 762 (34.0) | 190 (31.1) | |
| Public | 1,198 (23.7) | 417 (18.9) | 650 (29.0) | 131 (21.4) | |
| Uninsured | 1,080 (21.3) | 354 (16.0) | 598 (26.7) | 128 (21.0) | |
| Unknown | 654 (12.9) | 261 (11.8) | 231 (10.3) | 162 (26.5) | |
| Diagnosis year | |||||
| 2014 | 1,031 (20.4) | 491 (22.2) | 442 (19.7) | 98 (16.0) | 0.303 |
| 2015 | 976 (19.3) | 394 (17.8) | 428 (19.1) | 154 (25.2) | |
| 2016 | 1,027 (20.3) | 431 (19.5) | 458 (20.4) | 138 (22.6) | |
| 2017 | 980 (19.4) | 434 (19.7) | 449 (20.0) | 97 (15.9) | |
| 2018 | 1,046 (20.7) | 458 (20.7) | 464 (20.7) | 124 (20.3) |
Note: Boldface indicates statistical significance (p<0.05).
Data retrieved from incident cervical cancer data provided by Texas Cancer Registry, 2014–2018.
Cervical cancer staging definition: Early-stage (SEER summary stage 0 [in situ, intraepithelial, noninvasive] and 1 [localized]); late-stage (SEER summary stage 2–4 [regional spread] and 7 [distant spread]); unstaged (SEER summary stage 9 [missing or unknown stage]) cervical cancer at diagnosis.
p-value derived from chi-square tests comparing characteristics of ECC and LCC groups for categorical variables and t-test of difference in means for the continuous variable.
Patients of non-White and non-Black races were recoded into the Other category.
Payer at diagnosis: private, types of private insurance; public/government, includes Medicare, Medicaid, TRICARE, military, Veterans Affairs, Indian/Public Health Service; uninsured, includes not insured, self-pay; unknown, insurance not otherwise specified, insurance status unknown.
CC, incident cervical cancer; ECC, Early-stage cervical cancer; LCC, Late-stage cervical cancer; NHB, non-Hispanic Black; NHW, non-Hispanic White; SEER, Surveillance, Epidemiology, and End Results.